David B. Jackson

发表

Core Algorithms of the Maui Scheduler

Mark J. Clement, Quinn Snell, David B. Jackson, 2001, JSSPP.

The Performance Impact of Advance Reservation Meta-scheduling

Mark J. Clement, Quinn Snell, David B. Jackson, 2000, JSSPP.

Preemption Based Backfill

Mark J. Clement, Quinn Snell, David B. Jackson, 2002, JSSPP.

High Performance Scheduling for Windows NT

Mark J. Clement, Quinn Snell, David B. Jackson, 1999, PDPTA.

Simulation based HPC workload analysis

Quinn Snell, Heather L. Jackson, David B. Jackson, 2001, Proceedings 15th International Parallel and Distributed Processing Symposium. IPDPS 2001.

Maui scheduler: a multifunction cluster scheduler

David B. Jackson, 2001 .

Design Theory and Computational Modeling Tools for Systems with Wear

Nam-Ho Kim, W. Gregory Sawyer, David B. Jackson, 2007 .

Hierarchical Analysis of Dependency in Metabolic Networks

Julien Gagneur, Georg Casari, David B. Jackson, 2003, Bioinform..

In Silico Profiling of Clinical Phenotypes for Human Targets Using Adverse Event Data

Theodoros G Soldatos, Guillaume Taglang, David B Jackson, 2018, High-throughput.

Use of "big data" in drug discovery and clinical trials.

Guillaume Taglang, David B Jackson, David B. Jackson, 2016, Gynecologic oncology.

EMT is the dominant program in human colon cancer

David B Jackson, David B. Jackson, T. Yeatman, 2011, BMC Medical Genomics.

Relationships of clinical response to relevant molecular signal during Phase I testing of Aurora Kinase A inhibitor: Retrospective assessment

David B Jackson, David B. Jackson, N. Senzer, 2015 .

Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2022, CPT: pharmacometrics & systems pharmacology.

Application of a patient‐centered reverse translational systems‐based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2022, Clinical and translational science.

The COVID-19 explorer—An integrated, whole patient knowledge model of COVID-19 disease

Theodoros G. Soldatos, David B. Jackson, K. Hornischer, 2022, Frontiers in Molecular Medicine.

Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2023, Frontiers in Molecular Medicine.

Serum-based microRNAs: Are we blinded by potential?

David B Jackson, David B. Jackson, 2009, Proceedings of the National Academy of Sciences.

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2020, International journal of molecular sciences.

Radioimmunotherapy in Non-Hodgkin’s Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2019, Pharmaceuticals.

Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting

Rebecca Racz, Theodoros G Soldatos, David B Jackson, 2020, Clinical pharmacology and therapeutics.

Bioinformatory‐assisted analysis of next‐generation sequencing data for precision medicine in pancreatic cancer

David B Jackson, David B. Jackson, J. Lindberg, 2017, Molecular oncology.

Personalized cancer medicine—advances and socio-economic challenges

David B Jackson, David B. Jackson, A. Sood, 2011, Nature Reviews Clinical Oncology.

Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine

David B Jackson, David B. Jackson, A. Picker, 2011, Expert review of molecular diagnostics.

Molecular perspectives on the non-responder phenomenon.

David B Jackson, David B. Jackson, 2009, Drug discovery today.

Erythropoietin Stimulates Tumor Growth via EphB4.

Jie Huang, Bulent Ozpolat, David B Jackson, 2015, Cancer cell.

Precision Oncology—The Quest for Evidence

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2019, Journal of personalized medicine.

Src activation by β-adrenoreceptors is a key switch for tumor metastasis

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2012, Nature Communications.

Src activation by b-adrenoreceptors is a key switch for tumour metastasis

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2013 .

Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2020, Cancers.

Association Between Serotonin Syndrome and Second‐Generation Antipsychotics via Pharmacological Target‐Adverse Event Analysis

Rebecca Racz, David B Jackson, Theodoros G. Soldatos, 2018, Clinical and translational science.

A case study of a patient‐centered reverse translational systems‐based approach to understand adverse event profiles in drug development

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2022, Clinical and translational science.

Drug profiling: knowing where it hits.

David B Jackson, David B. Jackson, Alejandro Merino, 2010, Drug discovery today.

Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide

David B. Jackson, M. Stein, Ulrike Ziehm, 2023, Cancers.